Composition and dressing with nitric oxide
Abstract
A dressing composition for use as a skin dressing comprises an elastomeric-adhesive composition, and a zeolite comprising releasably adsorbed nitric oxide. The zeolite may comprise a transition metal cation such as Co, Fe, Mn, Ni, Cu, Zn, Ag or a mixture thereof as an extra-framework metal cation, preferably Zn. The elastomeric adhesive composition may be a hydrocolloid-adhesive composition comprising, hydrocolloid and elastomer. The dressing composition releases nitric oxide, which may have beneficial effects, when used on wounds or moist skin, with a substantially constant release rate over a long period of time. A dressing including a layer of the dressing composition has a backing layer and may have a release liner removably attached to the skin-contacting surface of the dressing layer.
Claims
exact text as granted — not AI-modified1 . A dressing composition for use as a skin dressing comprising:
i) an elastomeric-adhesive composition, and ii) a zeolite comprising releasably adsorbed nitric oxide.
2 . The composition of claim 1 comprising from 99.5 to 30% by weight of an elastomeric-adhesive composition, and from 0.5 to 70% by weight of zeolite.
3 . The composition of claim 1 wherein the zeolite is selected from zeolite P, zeolite A, zeolite X, zeolite Y and mixtures thereof.
4 . The composition of claim 3 wherein the zeolite is zeolite A.
5 . The composition of claim 1 wherein the zeolite comprises a transition metal cation as an extra-framework metal cation providing positive charge.
6 . The composition of claim 5 wherein 20 molar % or more of the extra framework cation of the zeolite is a transition metal cation.
7 . The composition of claim 5 wherein the transition metal cation is Co, Fe, Mn, Ni, Cu, Zn, Ag or a mixture thereof.
8 . The composition of claim 1 wherein the zeolite comprises at least 0.5 mmol/g of releasably adsorbed nitric oxide.
9 . The composition of claim 1 wherein the zeolite is a dry zeolite.
10 . The composition of claim 1 wherein the volume mean particle diameter of the zeolite is from 0.1 to 20 μm, preferably from 0.5 to 10 μm.
11 . (canceled)
12 . The composition of claim 1 wherein the elastomeric adhesive composition is a hydrocolloid-adhesive composition comprising, by weight of the hydrocolloid-adhesive composition, from 15 to 70% by weight of a hydrocolloid and from 30 to 85% by weight of an elastomer.
13 . The composition of claim 1 further comprising an additional pharmaceutically active agent.
14 . The composition claim 13 wherein the additional pharmaceutically active agent is a wound-treatment agent.
15 . (canceled)
16 . A dressing for application to skin comprising a backing layer holding a dressing layer comprising a skin contacting surface and the dressing composition of claim 1 .
17 . The dressing of claim 16 further comprising a release liner removably attached to the skin-contacting surface of the dressing layer.
18 . The composition of claim 5 wherein 50 molar % or more of the extra framework cation of the zeolite is a transition metal cation.
19 . The composition of claim 5 wherein the transition metal cation is Zn, Cu, Ag or a mixture thereof.
20 . A method for the treatment of the human or animal body by application thereto of a composition according to claim 1 .
21 . The method for treatment of claim 20 for treatment selected from the group consisting of: treatment of wounds, treatment of erectile dysfunction, treatment of anorgasmia, enhancement of transdermal drug delivery, vasodilation as a precursor to surgical insertion, treatment of skin diseases, treatment of neuropathy and treatment of inflammation.Join the waitlist — get patent alerts
Track US2011280927A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.